Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-68.56	61.36	195.14
Graham Fair Price	39.38	60.80	43.62
PEG	-6.57	0.36	0.39
Price/Book	-1.34	2.75	2.79
Price/Cash Flow	90.07	185.45	97.57
Prices/Earnings	-47.73	32.89	62.93
Price/Sales	-6.83	14.01	15.03
Price/FCF	90.07	185.45	97.57
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	6.03	0.46	0.43
Operating Margin	77.42	0.17	0.09
ROA	84.46	< 0.005	< 0.005
ROE	0.01	0.02	88.76
ROIC	< 0.005	0.02	95.00
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.12	0.01	711.14
Dividends QOQ	0.04	< 0.005	-94.79
EBIT QOQ	0.26	0.90	249.79
EPS QOQ	1.62	0.91	-44.05
FCF QOQ	-0.30	-0.47	-59.87
Revenue QOQ	-0.07	0.07	-3.82
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	111.00	106.02	-4.48
Days Sales Outstanding (DSO)	43.36	45.65	5.30
Inventory Turnover	0.81	0.85	4.69
Debt/Capitalization	0.39	0.41	6.13
Quick Ratio	0.46	0.79	72.46
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	87.32	88.59	1.45
Cash	4.07	11.13	173.06
Capex	-0.40	-0.46	-15.75
Free Cash Flow	2.50	1.32	-47.34
Revenue	16.22	17.43	7.42
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.08	1.41	30.46
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	34.01	11.11	-67.34
Naive Interpretation	Member

06 - Financial Health · Weak

Rating